REFERENCES
- Denning DW. Aspergillus species. In: GL Mandell, JE Bennett, R Dolin (eds): Principles and Practice of Infectious Diseases. 5th ed Churchill Livingstone, New York, 2000; 2674-26.
- Steinfeld S, Durez P, Hauzeur JP, Motte S, Appelboon T. Articular aspergillosis:Two case reports and review of the literature. Br J Rheumatol 1997: 36: 1331–1334.
- Alvarez L, Calvo E, Abril C. Articular aspergillosis: Case report. Clin Infect Dis 1995; 20: 457–460.
- Bodur H, Ozoran K, Colpan A, Balaban N, Tabak Y, Kulacoglu S. Arthritis and osteomyelitis due to Aspergillus fumigatus. A 17 years old boy with chronic granulomatous disease. Ann Clin Microbiol Antimicrob 2003; 2: 2.
- Panigrahi S, Nagler A, Or R, Wolf DG, Slavin S, Shapira MY. Indolent aspergillus arthritis complicating fludara-bine-based non-myeloablative stem cell transplantation. Bone Marrow Transplant 2001; 27: 659–661.
- Gunsiliue E, Lass-Florl C, Mur E, Gabl C, Gastl G, Petzer AL. Aspergillus osteoarthritis in acute lympoblastic leukemia. Ann Hematol 1999; 78: 529–530.
- Garcia-Porrua C, Blanco FJ, Atanes A, Tarres P, Galdo F. Septic arthritis by Aspergillus fumigatus: a complication of corticosteroid infiltration. Br J Rheumatol 1997; 36: 610–611.
- Franco M, Van Elslende L, Robino C, et al. Aspergillus arthritis of the shoulder in a renal transplant recipient. Failure of itraconazole therapy. Rev Rheum Engl Ed. 1995; 62: 215–218.
- Lortholary O, Mouas-Dupuy H, Dupont B, Lutsar I, Fain O. Voriconazole (VCZ) for bone aspergillosis (BA): a world-wide experience of 19 cases. Program and abstracts the 43rd Annual ICAAC; September 14-17, 2003; Chicago, Illinois. Abstract M-979.
- Wingard JR. Lipid formulations of amphotericins: Are you a lumber or a splitter? Clin Infect Dis 2002; 891-895.
- Stevens DA, Bennett JE. Antifungal agents. In: GL Mandell, JE Bennett, R Dolin (eds): Principles and Practice of Infectious Diseases. 5th ed Churchill Livingstone New York, 2000; 2950-2956.
- Walsh TJ, Hiemenz JW, Seibel NL. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998: 26; 1383-1396.
- Mehta J. Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations? Leuk Res 1997; 21: 183–188.
- Barone JA, Moskowitz BL, Guarnieri J. Enhanced bioavailability of itraconazole in hydroxypropyl B-cyclodextrin solution versus capsules in healthy volunteers. Antimicrob Agents Chemother 1998; 42: 1862–1865.